Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Anania

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Hepatology (Baltimore, Md.)|November 2, 2017
Therapy for steatohepatitis: Do macrophages hold the clue?Reben Raeman, Frank A Anania
Gastroenterology|May 15, 2007
Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver diseaseSamir Parekh, Frank A Anania
Digestive Diseases and Sciences|March 29, 2007
Chlorzoxazone as a cause of acute liver failure requiring liver transplantationJames Jackson, Frank A Anania
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 17, 2008
Increased liver enzyme levels and HNF-1beta gene mutationVanitha Bala, Frank A Anania
Gastroenterology|September 30, 2010
Recent changes in relationships between medical school physicians and industryFrank A Anania, Vincent W Yang
Minerva Medica|June 1, 1996
[Effect of specific immunotherapy on peripheral T-lymphocytes in atopic patients]A Anania, G Marino, G Cascio
Critical Care Clinics|June 11, 2002
Hepatorenal syndrome. Definition, pathophysiology, and interventionAndrew E Briglia, Frank A Anania
Current Gastroenterology Reports|March 6, 2007
Treatment of fibrosis in nonalcoholic fatty liver diseaseMaarouf A Hoteit, Frank A Anania
Journal of the American College of Cardiology|June 29, 2019
Oral Anticoagulants in Liver Disease: Not Child's PlayElaine M Hylek, Frank A Anania
Hepatology (Baltimore, Md.)|March 6, 2013
Connecting the dots from fatty acids to nonalcoholic steatohepatitis: epigenetics in the spotlightFlorin M Selaru, Frank A Anania
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Hepatology (Baltimore, Md.)|November 2, 2017
Therapy for steatohepatitis: Do macrophages hold the clue?Reben Raeman, Frank A Anania
Gastroenterology|May 15, 2007
Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver diseaseSamir Parekh, Frank A Anania
Digestive Diseases and Sciences|March 29, 2007
Chlorzoxazone as a cause of acute liver failure requiring liver transplantationJames Jackson, Frank A Anania
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 17, 2008
Increased liver enzyme levels and HNF-1beta gene mutationVanitha Bala, Frank A Anania
Gastroenterology|September 30, 2010
Recent changes in relationships between medical school physicians and industryFrank A Anania, Vincent W Yang
Minerva Medica|June 1, 1996
[Effect of specific immunotherapy on peripheral T-lymphocytes in atopic patients]A Anania, G Marino, G Cascio
Critical Care Clinics|June 11, 2002
Hepatorenal syndrome. Definition, pathophysiology, and interventionAndrew E Briglia, Frank A Anania
Current Gastroenterology Reports|March 6, 2007
Treatment of fibrosis in nonalcoholic fatty liver diseaseMaarouf A Hoteit, Frank A Anania
Journal of the American College of Cardiology|June 29, 2019
Oral Anticoagulants in Liver Disease: Not Child's PlayElaine M Hylek, Frank A Anania
Hepatology (Baltimore, Md.)|March 6, 2013
Connecting the dots from fatty acids to nonalcoholic steatohepatitis: epigenetics in the spotlightFlorin M Selaru, Frank A Anania
Pageof 11